Glenmark Pharmaceuticals Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Glenmark Pharmaceuticals Limited Company Profile :

Glenmark Pharmaceuticals Limited is an Indian pharmaceutical company which is focused on developing and marketing branded and generic formulations. It focuses on manufacturing products across therapeutic areas of dermatology, respiratory and oncology. Its active pharmaceuticals ingredients (API) business spans over 80 countries, including regulated markets of the United States, Europe, Japan and Canada.

Company has offices in over 40 countries, and operates approximately 20 manufacturing facilities in over five countries. It operates over five research and development (R&D) centers.


Glenmark Pharmaceuticals ResultsBSE Code : 532296
NSE Symbol :  GLENMARK
ISIN No. : INE935A01035
Industry :  Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Glenmark Pharmaceuticals or you are an stock market analyst then i am sure you might for Quarterly Results of Glenmark Pharmaceuticals.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Glenmark Pharmaceuticals. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Glenmark Pharmaceuticals.

Glenmark Pharmaceuticals Q1 Results 2016-17 :

Glenmark Pharmaceuticals will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Glenmark Pharmaceuticals will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Glenmark Pharmaceuticals will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Glenmark Pharmaceuticals will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Glenmark Pharmaceuticals will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17  Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Glenmark Pharmaceuticals Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 6113.50 7559.99
Other Income  117.28  20.00
Total Income 6230.78  7579.99
Expenditure  -4357.85  -6377.90
Interest  -36.22 -178.88
Depreciation  -112.10 -251.76
PBT  1724.61 1023.21
Tax  -256.18 -303.30
Net Profit  1468.43 719.90
Equity  28.22 28.22
EPS  52.31 25.65

Note : If you like this information about Glenmark Pharmaceuticals Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.